Meihua International Medical Technologies Co., Ltd. (MHUAF)
Full history for every metric is available with a Kvantra account
Meihua International Medical Technologies Co., Ltd. (MHUAF)
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 89 | 104 | 103 | 97 | 97 | 62 | 62 | - |
| Operating profit | $m | 8 | 8 | ||||||
| Net profit | $m | 19 | 21 | 6 | 12 | 11 | 7 | 7 | - |
| EPS reported | $ | 18.04 | 15.09 | ||||||
| Operating cashflow per share | $ | 1.52 | 0.82 | ||||||
| Capex per share | $ | 0.04 | 0.02 | ||||||
| FCF per share | $ | 1.47 | 0.80 | ||||||
| Free cash flow | $m | 1 | 1 | ||||||
| Net debt | $m | -6 | -6 | ||||||
| Book value equity | $m | 189 | 189 | ||||||
| Book value per share | $ | 502.4 | 271.6 | ||||||
| Number of shares | m | 0.38 | 0.7 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 0.11 | - | ||||||
| P/B LTM | x | 0.00 | 0.00 | ||||||
| P/S LTM | x | 0.01 | 0.01 | ||||||
| P/FCF LTM | x | 1.39 | 1.39 | ||||||
| EV/EBITDA LTM | x | -0.61 | -0.61 | ||||||
| EV/Sales LTM | x | -0.09 | -0.02 | ||||||
| Earnings Yield LTM | % | +909.09% | +1.43% | ||||||
| FCF Yield | % | +71.90% | +71.90% | ||||||
| Quality | |||||||||
| ROE | % | +3.59% | +3.83% | ||||||
| ROIC | % | +3.02% | +3.02% | ||||||
| Operating margin | % | +13.41% | +13.41% | ||||||
| Gross margin | % | +30.74% | +30.88% | ||||||
| FCF/Sales | % | +0.90% | +0.90% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -54.90% | -62.28% | ||||||
| Sales Growth YoY | % | -36.24% | -36.24% | ||||||
| Net Income Growth YoY | % | -37.46% | -37.46% | ||||||
| FCF Growth | % | -96.18% | -96.18% | ||||||
| Operating Profit Growth | % | -42.12% | -42.12% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.06 | 0.06 | ||||||
| Net Debt/EBITDA | x | -0.70 | -0.70 | ||||||
| EBIT/Net interest | x | 34.30 | 22.74 | ||||||
| Net debt/market cap | % | +11.66% | +1.89% | ||||||
| Net debt/Equity | x | -0.03 | -0.03 | ||||||
| Gross debt/equity | x | 0.05 | 0.05 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Meihua International Medical Technologies Co., Ltd. is a Chinese company dedicated to the innovation, production, and distribution of a wide array of medical devices. Operating primarily within the People's Republic of China, its comprehensive product portfolio spans various regulatory classifications. The company offers numerous Class I disposable medical supplies, such as medical X-ray and dry films, dry laser imagers, gauze bandages, and examination gloves. It also provides pharmaceutical packaging, including low-density polyethylene eye drop bottles and high-density polyethylene tablet bottles. Its Class II inventory comprises critical disposable instruments and kits for medical procedures, including complete anesthesia kits, specialized medical brushes, various examination and urethral catheterization sets, endotracheal intubation devices, medical masks, anal bags, and suction connecting tubes. For Class III disposable medical devices, Meihua manufactures advanced solutions like single-use infusion pumps, sophisticated anesthesia puncture kits, and electronic pump systems. Beyond these, the company also produces disposable plastic baby bottles and components like NB/PSN rubber covers and 8.2mL folded spoons for tools and containers. It specializes in Class II 6866 medical polymer materials and products, such as transfusion equipment, pipelines, and endotracheal intubation for respiratory care, alongside traditional medical X-ray films and multi-functional self-extracting X-ray film machines. Meihua caters to a broad customer base, including hospitals, pharmacies, medical institutions, and medical equipment companies. Its products are distributed globally, reaching markets throughout Europe, North America, South America, Asia, Africa, and Oceania. Founded in 1991, the company is headquartered in Yangzhou, People's Republic of China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Meihua International Medical Technologies Co., Ltd. (MHUAF)
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Meihua International Medical Technologies Co., Ltd. is a Chinese company dedicated to the innovation, production, and distribution of a wide array of medical devices. Operating primarily within the People's Republic of China, its comprehensive product portfolio spans various regulatory classifications. The company offers numerous Class I disposable medical supplies, such as medical X-ray and dry films, dry laser imagers, gauze bandages, and examination gloves. It also provides pharmaceutical packaging, including low-density polyethylene eye drop bottles and high-density polyethylene tablet bottles. Its Class II inventory comprises critical disposable instruments and kits for medical procedures, including complete anesthesia kits, specialized medical brushes, various examination and urethral catheterization sets, endotracheal intubation devices, medical masks, anal bags, and suction connecting tubes. For Class III disposable medical devices, Meihua manufactures advanced solutions like single-use infusion pumps, sophisticated anesthesia puncture kits, and electronic pump systems. Beyond these, the company also produces disposable plastic baby bottles and components like NB/PSN rubber covers and 8.2mL folded spoons for tools and containers. It specializes in Class II 6866 medical polymer materials and products, such as transfusion equipment, pipelines, and endotracheal intubation for respiratory care, alongside traditional medical X-ray films and multi-functional self-extracting X-ray film machines. Meihua caters to a broad customer base, including hospitals, pharmacies, medical institutions, and medical equipment companies. Its products are distributed globally, reaching markets throughout Europe, North America, South America, Asia, Africa, and Oceania. Founded in 1991, the company is headquartered in Yangzhou, People's Republic of China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free